Pulmonary & Sleep Medicine Research
Regeneron Study
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Patients with Moderate-to-Serve Asthma (R668-AS-1903)
Age: 18-55 years old
Sex at Birth: All
Sex at Birth: All
Type: Translational Study
Condition: Moderate to Severe Asthma
Condition: Moderate to Severe Asthma
Healthy Participants: Yes
Location: UH Cleveland Medical Center
Location: UH Cleveland Medical Center
Learn More About This Research Study
For more information, please contact Katie Northcutt, RN, BSN at 216-286-0220 or complete the online form below.
Study Purpose
The purpose of this study is to determine the safety and effectiveness of a study drug called dupilumab, on exercise capacity in people who have moderate-to-severe asthma.
Who Can Participate
Participants between 18-55 years old diagnosed with asthma may be eligible for this study.
- STUDYID20200300
- NCT04203797